MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.athoracsur.2019.01.061

Медицинская библиотека · The Annals of thoracic surgery · 2019

Impact of Bleeding Revision on Outcomes After Left Ventricular Assist Device Implantation.

Angleitner Philipp, Simon Paul, Kaider Alexandra, Wiedemann Dominik, Dimitrov Kamen, Schlöglhofer Thomas, Rajek Maria Angela, Riebandt Julia, Laufer Günther, Zimpfer Daniel

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Few reports have described associations between a bleeding revision and outcomes after implantation of a continuous-flow left ventricular assist device (LVAD).

METHODS

We retrospectively analyzed all adult recipients of a continuous-flow LVAD who were operated on between January 2006 and December 2016 at the Division of Cardiac Surgery, Medical University of Vienna (N = 257). LVAD types were HeartWare HVAD (Medtronic, Minneapolis, MN), HeartMate II (Abbott [Thoratec], Abbott Park, IL), and HeartMate 3 (Abbott [Thoratec]). The primary outcome variable was survival during LVAD support. Secondary outcome variables were rates of prolonged ventilation, intensive care unit stay, hospital stay, renal replacement therapy, and stroke. We additionally investigated risk factors for a bleeding revision.

RESULTS

Thirty-six patients (14%) underwent surgical revision for bleeding. In a multivariable Cox proportional hazards model, bleeding revision was associated with significantly reduced survival during LVAD support (3 months: hazard ratio [HR], 2.04; 95% confidence interval [CI], 1.20 to 3.48; 6 months: HR, 1.63; 95% CI, 0.95 to 2.82; 12 months: HR, 1.30; 95% CI, 0.69 to 2.46; 24 months: HR, 1.04; 95% CI 0.48 to 2.26; overall p = 0.007). Rates of secondary outcome variables were substantially higher in the revision group compared with patients who survived the hospital stay without a bleeding revision. Concomitant implantation of a temporary right ventricular assist device (p = 0.002) and age (p = 0.028) were independent risk factors for a bleeding revision.

CONCLUSIONS

A bleeding revision is associated with significantly reduced survival and substantially increased morbidity during LVAD support. Preoperative, intraoperative, and postoperative prophylactic strategies may help to prevent this life-threatening complication.

Для цитирования: Angleitner Philipp, Simon Paul, Kaider Alexandra, Wiedemann Dominik, Dimitrov Kamen, Schlöglhofer Thomas, Rajek Maria Angela, Riebandt Julia, Laufer Günther, Zimpfer Daniel. Impact of Bleeding Revision on Outcomes After Left Ventricular Assist Device Implantation.. The Annals of thoracic surgery. 2019. DOI: 10.1016/j.athoracsur.2019.01.061.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.